FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

From Regulation to Restriction: Europe’s Expanding Speech Laws and the Shadow of Prophecy

Europe’s Expanding Digital Crackdown Raises Free Speech Concerns Across…
FDA Authorizes Novavax COVID Vaccine

A Shaken Union: Europe’s Economic Struggles and the Prophetic Implications

The Four Horsemen of Europe’s Decline Europe still evokes…
FDA Authorizes Novavax COVID Vaccine

Trump Revokes Obama-Era Climate Rule, Marking Major Shift in Federal Authority

Trump Revokes Obama-Era Climate Rule, Marking Major Shift in…